Americas' Attractiveness To Drugmakers Remains Stable

To read the full article, please choose one of the following options:

BMI View: The attractiveness of pharmaceutical markets in many North and South American countries has been relatively stable in BMI's Q312 Pharmaceutical Risk/Rewarding Ratings (RRRs). Brazil remains the region's most attractive place for pharmaceutical companies and Mexico has offered improving opportunities for multinational drugmakers. We also have a favourable view towards the pharmaceutical markets in Colombia and Chile, but are cautious about Argentina and